NDC 10157-9409 - Blistex Baby Kanka
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 10157-9409
- Package NDCs from labels
- 10157-9409-1
- Manufacturer
- Blistex Inc.
- Effective date
- 2015-01-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Blistex Baby Kanka ® Gel | Blistex Inc. | 2015-01-22 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10157-9409-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-dd11-f424-e053-dadaa90a57ce | Blistex Baby Kanka ® Gel |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10157-9409-1 | Blistex Baby Kanka | 10 g in 1 TUBE | GEL | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10157-9409 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | 1 package rows | 20150129_b70ff808-43d3-4a14-867e-b56f9db9da87.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Benzocaine | ACTIVE INGREDIENT | U3RSY48JW5 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| Benzocaine | ACTIVE MOIETY | U3RSY48JW5 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| POLYETHYLENE GLYCOL 3350 | INACTIVE INGREDIENT | G2M7P15E5P | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 7a2d8dab-750f-43c1-933c-4169a840c60c | 2023-06-20 | Warnings, Adverse reactions | G2M7P15E5P |
| HurriCaine Topical Anesthetic | BENZOCAINE | Beutlich Pharmaceuticals, LLC | c979e958-2042-471a-bf03-e84e68620106 | 2023-06-20 | Warnings | U3RSY48JW5 |
| good sense clearlax | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | 9858edef-cdb2-4ac4-8e4b-ba0720a24e41 | 2023-06-01 | Warnings | G2M7P15E5P |
| dg health clearlax | POLYETHYLENE GLYCOL 3350 | Dolgencorp Inc | ffae36fd-2fb7-4afb-a7f8-29c700a477fb | 2023-05-04 | Warnings | G2M7P15E5P |
| Virility Liquescence | AVENA SATIVA, DAMIANA, BERBERIS VULGARIS, EPIMEDIUM GRANDIFLORUM, GLYCERINUM, SABAL SERRULATA, IODIUM, LECITHIN, FERRUM MURIATICUM, NATRUM MURIATICUM, AGNUS CASTUS, BUFO RANA, CINCHONA OFFICINALIS, HUMAN GROWTH HORMONE (HGH), ORCHITINUM (BOVINE), PHOSPHORICUM ACIDUM, PHOSPHORUS, SELENIUM METALLICUM, ZINCUM VALERIANICUM, OOPHORINUM (SUIS), SEPIA | Nutritional Specialties, Inc. | 81cc3e2b-f95e-4ba4-a15f-c07b4def0e2f | 2023-03-29 | Warnings | PDC6A3C0OX |
| laxative | POLYETHYLENE GLYCOL 3350 | Rite Aid Corporation | 3ebe9191-8e0a-41cf-b759-82ecce4f50e4 | 2023-02-10 | Warnings | G2M7P15E5P |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | G2M7P15E5P |
| dg health clearlax | POLYETHYLENE GLYCOL 3350 | Dolgencorp, LLC | 94280ce4-b2cf-451d-a660-b26ab1a2d3f0 | 2023-02-06 | Warnings | G2M7P15E5P |
| clearlax | POLYETHYLENE GLYCOL 3350 | H E B | 0b4b752d-045d-4ff0-8e50-5607d1a841a7 | 2023-01-26 | Warnings | G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | 435db89c-1e32-4da5-b7d0-15e407162715 | 2023-01-24 | Warnings | G2M7P15E5P |
| Orajel Gum Pain 3X Medicated | BENZOCAINE, MENTHOL, ZINC CHLORIDE | Church & Dwight Co., Inc. | 9a1632ad-2b47-5653-e053-2995a90ae0d9 | 2023-01-20 | Warnings | U3RSY48JW5 |
| basic care clearlax | POLYETHYLENE GLYCOL 3350 | Amazon.com Services LLC | 21897170-0d5e-4326-bebf-10258e0aca82 | 2022-12-08 | Warnings | G2M7P15E5P |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | PDC6A3C0OX |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | PDC6A3C0OX |
| POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | Geri-Care Pharmaceutical Corp | f4c7eb80-d8d5-406d-90d0-9d17914d71f2 | 2022-11-24 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Gericare Pharmaceuticals | 5d0d2c14-24e6-45b4-92f6-4eaf5da72cdd | 2022-10-28 | Warnings | G2M7P15E5P |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | PDC6A3C0OX |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | PDC6A3C0OX |
| Equate ClearLAX | POLYETHYLENE GLYCOL 3350 | WALMART INC. | c5c13378-3c08-415f-8ab4-8a18d6300ca8 | 2022-09-08 | Warnings | G2M7P15E5P |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.